Clinical trial · Interventional
Self-Management Intervention for Breathlessness in Lung Cancer
A Pilot Trial of a Self-Management Intervention for Breathlessness in Lung Cancer
NCT01585883CI-TRIAL-00038460completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to investigate the suitability and practicality of a coaching and support intervention in helping patients to use daily strategies for managing breathlessness. Also, the investigators will try to understand how useful it is in helping patients to reduce intensity of breathlessness and its impact their quality of life.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breathlessness | — | UNRESOLVED | — |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Self-management Intervention | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Self-management Intervention
- description
- Individual, face-to-face 7-session self-management intervention delivered by a specialist oncology nurse/clinical case manager as a home-based approach using a manual for each session.
- interventionNames
- Behavioral: Self-management Intervention
- type
- ACTIVE_COMPARATOR
- label
- Standard of care
- description
- Patients in this condition will receive usual care as decided by their oncology clinic team or physician.
- interventionNames
- Behavioral: Self-management Intervention
Primary outcomes (3)
- measure
- Perceived severity of breathlessness
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion criteria: Eligible participants are women and men with lung cancer (stage I to IV) receiving chemotherapy and/or radiotherapy 1. Report breathlessness occurrence (any score \>=3) on a Numerical Rating Scale (0-no breathlessness; 10 - worst breathlessness) during standardized routine distress screening and/or report breathlessness as a symptom to their health care provider 2. Normal cognitive function as measured by a score of \<20 on the Short Orientation Memory Cognitive Test (SOMC) 3. ECOG performance score of 0 to 2 4. Estimated life expectancy of \>3 months as per physician 5. Reside within a 45 kilometre driving radius of Princess Margaret Hospital 6. Oxygen saturation \>90% at rest on room air or with oxygen 7. Available for 8 consecutive weeks of the study. Exclusion criteria: 1. Patients who have received surgery alone as the primary treatment for lung cancer 2. Unstable acute asthma or left heart failure or coronary artery or valvular heart disease or neuromuscular disease 3. Inability to comply with the study protocol including completion of the questionnaires in English 4. Major psychiatric disorder identified by the physician.
References
Publications (0)
Data not yet available
No reference posted for this study.